Aspartate beta-hydroxylase is a prognostic factor in gallbladder cancer with the function of promoting tumorigenesis and chemoresistance

Aspartate beta-hydroxylase is a prognostic factor in gallbladder cancer with the function of promoting tumorigenesis and chemoresistance

AimsGallbladder cancer is characterized by a dismal prognosis, with a limited number of biological markers currently identified for the carcinogenesis, progression and prognosis of gallbladder cancers (GBCs). The discovery of efficacious biomarkers is crucial for enhancing the prognosis of gallbladd...

Full description

Saved in:
Bibliographic Details
Main Authors: Luo Yuan, Huang Yunpeng, Li Xiong, Yu Wen, Wang Yongxiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Endocrinology
Subjects:
gallbladder cancer
ASPH
metastasis
immune evasion
drug resistance
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2025.1452345/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2025.1452345/full

Similar Items